Dr Tim Tasker

Executive Vice President Clinical Development

Dr Tim Tasker, 55, is Executive Vice President Clinical Development of Evotec. He joined the Company in July 2005 and brings more than 23 years of global clinical development and business expertise at Beecham, SmithKline Beecham (SB) and now GlaxoSmithKline (GSK) to the Company. Before joining Evotec, Dr Tasker was Vice President Global Clinical Units, Clinical Pharmacology and Discovery Medicine and Member of the GSK Global Safety Board. During his career Dr Tasker has gained deep drug development expertise at all stages. He has a strong background in clinical pharmacology and a particular ability in early development to proof-of-concept in man (Phase I, Phase IIa and Clinical Pharmacology Programs). Through most of the 90s he headed SB's clinical pharmacology across Europe, where he was responsible for the design and implementation of early development plans for 50% of SB's portfolio. In addition, Dr Tasker was a key member of the Neurosciences Therapeutic Area Team.

Tim Tasker has a Physiological Sciences first Class Honours Degree (BA Hons) from University of Oxford and a Medical Degree (MBBS) from London University, England. He is a Fellow of the Royal College of Physicians of the UK, and a Fellow and member of the Board of the Faculty of Pharmaceutical Medicine of the Royal College of Physicians.